Please enter verification code
Confirm
Prevalence of Hepatitis C Infections Among the Outpatient Population of Selected Hospitals Within Kaduna City, Nigeria
World Journal of Public Health
Volume 1, Issue 1, December 2016, Pages: 33-44
Received: Oct. 12, 2016; Accepted: Oct. 21, 2016; Published: Dec. 3, 2016
Views 3156      Downloads 106
Authors
Waje Timothy, Department of Microbiology, Faculty of Science, Kaduna State University, Kaduna, Nigeria
Dadah John Anthony, Department of Microbiology, Faculty of Science, Kaduna State University, Kaduna, Nigeria
Muhammad Yusha’u, Department of Microbiology, Faculty of Science, Bayero University, Kano, Nigeria
Orukotan Abimbola, Department of Microbiology, Faculty of Science, Kaduna State University, Kaduna, Nigeria
Ladan Zakari, Department of Chemistry, Faculty of Science, Kaduna State University, Kaduna, Nigeria
Article Tools
Follow on us
Abstract
Hepatitis C is a serious blood borne infection of the liver caused by the Hepatitis C Virus. The prolong infection of the liver by this Virus results to liver disease leading to its failure, cirrhosis or hepatocellular carcinoma (Liver cancer). The Hepatitis C Virus is a growing public health problem worldwide infecting an estimate of over 170 million people with majority from Africa and Asia. A total of 300 samples were collected from outpatients in six hospitals within the Kaduna City, Nigeria. Fifty samples were from each hospital. The outpatients’ Blood groups and Rhesus factors were identified using Blood group Anti-sera and their respective serum were screened for presence of HCV antibody using commercially available kits. Analysis of the results revealed a prevalence rate of 5.33% within the metropolis. This was regarded as high based on the global epidemiological HCV severity estimates reported by the American Center for Disease Control and Prevention (CDC). Chi square test for independence between two variables showed statistically significant associations between anti-HCV positivity and Sex/Gender with men more positive for anti- HCV than females (10.52%, P≤0.002), Blood grouping with more positive cases among blood group AB (15.39%, P≤0.03), Occupation, more positive cases observed among the unemployed (15.38%, P≤0.04) and patients with HIV/AIDS (40.00%, P≤0.001). These were identified as key risk factors for the spread of the Virus within the metropolis. The mean age observed for the distribution of the virus (a measure of central tendency) within the City was 32.20 (CI=32.20±2.01) years.
Keywords
Prevalence, Hepatitis C Virus, Hepatitis C Infections, Outpatient Population, Selected Hospitals, Kaduna Nigeria
To cite this article
Waje Timothy, Dadah John Anthony, Muhammad Yusha’u, Orukotan Abimbola, Ladan Zakari, Prevalence of Hepatitis C Infections Among the Outpatient Population of Selected Hospitals Within Kaduna City, Nigeria, World Journal of Public Health. Vol. 1, No. 1, 2016, pp. 33-44. doi: 10.11648/j.wjph.20160101.16
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Arash Mohebati, John Mihrah Davis and Donald E. Fry (2010). Current risks of occupational blood borne viral infections. Surgical infections volume 11. Number 3. pp. 1-8.
[2]
http://www.cdc.gov/hepatitis/hcv/index.htm
[3]
Inyama P. U., Uneke O. J., Anyama G. T., Njoku O. M., Idoko J. A. (2005). Prevalence of antibodies to Hepatitis C Virus among. Nigeria patients with HIV infections. Online Journal of Health and Allied Sciences. 2: 2 Volume 4, pp. 1-6.
[4]
Warren Levinson (2013). Review of Medical Microbiology and Immunology. Twelfth Edition. Mc Graw-Hill Publishers. pp. 329-331.
[5]
Robert E. Lanford, Elizabeth S. Hildebrandt-Eriksen, Andreas Petri, Robert Person, Morten Lindow, Martin E. Munk, Sakari Kauppinen and Henrik Qrum (2010). Therapeautic Silencing of Micro RNA-122 in primates with chronic hepatits C virus infections. National Institute of Health: 327 (5962). 198-201.
[6]
Richard A. Harvey, Cynthia Nau Cornelissen, Bruce D. Fisher (2013). Microbiology. Third Edition. Lippincoth Williams and Wilkins Publishers. pp. 289-291.
[7]
http://www.who.int/mediacentre/factsheets/fs164/en/.
[8]
Prescott, Harley and Kleins (2008). Microbiology. Seventh Edition. Mc Graw-Hill. pp. 936-940.
[9]
David Greenwood, Richard Slack, John Peutherer, Mike Barier (2007). Medical Microbiology: a guide to microbial infection, pathogenesis, Immunity, Laboratory Diagnosis and Control. Seventeenth Edition, Elsevier Publishers. pp. 531-533.
[10]
Jeffery C. Pommerville (2007). Alcamo’s Fundamentals of Microbiology. Eight Editions. Jones and Bartlett Publishers, pp. 451-455.
[11]
Tortora, G. J., Berdell, F. R. and Case, C. L. (2008). Microbiology, An Introduction. Ninth Edition. Pearson Education Inc Publishers. pp. 764-765.
[12]
Usman A. Ashfaq, Sobia Idrees (2014). Medicinal Plants against Hepatitis C Virus. World Journal of Gastroenterology. 20 (11). pp. 2941-2947.
[13]
K. R. Aneja, Pranay Jain, Raman Aneja (2008). A textbook of Basic and Applied Microbiology. New Age International publishers. pp. 693-695.
[14]
James A. Ndako, E. A. Onwuliri, Bunmi K. Olopade, Debby T. Olaolu, Olochi Ifeanyi, Josephin O. Awakan, Temitope G. Dojumo, Deborah O. Ogido (2014). Detection of HCV antibody among HIV seropositive women attending a rehabilitation centre. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS), Volume 9 issue 3 version 1 pp 40-44.
[15]
Dawurung, D. S; Bikbuk, D. N; Ajayi, Baba M. M. (2012). Prevalence of Hepatitis B and C coinfection among students of University of Maiduguri, Nigeria. Scholar Research Library, Archives of applied research. 4 (4) 1581-1584.
[16]
Afolabi, A. Y., Abraham A.; Oladapo, E. K; Fagbemi, A. H. (2012) Hepatitis C Virus in potential blood donors in Ibadan. Global Advance Research Journal of Microbiology Volume 1 pp. 155-159.
[17]
Godwin I. Achinge; Abraham O. Malu; Peter T. Mbave; Terkaa T. Bitto; Vivian, Shaahu; Hammed Mohammed; Michael. Misauno (2013). Prevalence of Hepatitis C in Makurdi North Central. Journal of Dental and Medical Services. Volume 7 issue 5, pp. 06-10.
[18]
J. A. Bala, A. H. Kawo, M. D. Mukhtar, A. Sarki, N. Magai, I. A. Aliyu and M. N. Sani (2012) Prevalence of Hepatitis C Virus among blood donors in some selected hospitals in Kano, Nigeria. International Research Journal of MicrobiSerology IRJM). ISSN: 2141. pp. 217-222.
[19]
Sheyin Z, Jatau E., Mamman A. I., Randawa A. J. and Bugwan A. I. (2012). Detection of Hepatitis C Virus among pregnant women in Kaduna State, Nigeria. Wudpecker Journal of Medical Sciences. Volume 12. pp. 12-15.
[20]
Isa, I. M., Abdullahi, S. A., Sani, M. A., Esona, M. D. (2015). Seroprevalence of hepatitis B virus in a tertiary institution in North Western Nigeria. African Journal of Microbiology Research. Volume. 9 (3), pp 171-179, 21.
[21]
Arya, R., Autonisamy, B., Kumar, S. (2012). Sample Size Estimation in Prevalence Studies, Indian Journal of Pediatrics Volume 79, Issue 11, pp 1482-1488.
[22]
http://www.socscistatistics.com/pvalues/chidistribution.aspx
[23]
http://www.statisticssolutions.com/non-parametric-analysis-chi-square/
[24]
Mohammed Hanafiah K., Groeger J., Flaxman S. T., Wiersma S. T. (2013). Global Epidemiology of Hepatitis C infections: new estimates of age specific antibody to HCV. CDC: 2015 Hepatology: Volume 57, Issue 4. pp. 1333-1342.
[25]
http://sites.stat.psu.edu/~mga/401/tables/Chi-square-table.pdf.
[26]
http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/hepatitis-c.
[27]
H. M. Mukhtar; M. Jones and J. Ashie (2006). Hepatitis C virus infections in Blood donor, an emerging risk to transfusion. Journal of annals of African Medicine. Volume 5. Number 4 pp. 182-184.
[28]
Sheyin Z, Jatau, D.; Mamman, A. I.; Randawa, A. J. (2012). Molecular epidemiology of hepatitis C Virus in Kaduna state, Nigeria. African journal of Clinical and experimental Microbiology. 13 (2): 61-65.
[29]
Zaccheaus Awortu Jeremiah, Baribefe Kaote, Fiekumo Buseri and Felix Emelike (2008). Prevalence of antibody to HCV in apparently healthy portharcourt blood donors and association with blood groups and other risk indicators. US national Liberary of Medicine: Blood Transfusion 6 (3): 150-155.
[30]
A. O. Udeze, R. A. Bamidele, I. O. Okonko and W. F. Sule (2011). Hepatitis C Virus (HCV) antibody Detection among First Year Students of University of Ilorin, Ilorin Kwara State, Nigeria. World Journal Medical Sciences. 6 (3). pp. 162-167.
[31]
Grace Rinmecit Pennap, Aliyu Yakubu, Odula Oyige and Joseph Forbi (2010). Prevalence of hepatitis Band C infections among people of a local community in Keffi, Nigeria. African Journal of Microbiology, Volume 4 (4), pp. 274-278.
[32]
M. A. Isa, B. S. Kolo, A. Ibrahim, Bulakarima and H. Dawud (2015). Prevalence of Hepatitis C Virus among children attending University of Maiduguri Teaching Hospital, Nigeria. International Journal of Science and Research Methodology. Volume 2: Issue 2.
[33]
Azeez-Akande O., Sarki A., Wokedi E., Olabode A. and Alabi p.(2010). Sereoprevalence and Risk Factors of Hepatitis C Virus in patients and blood donors in Kano, Nigeria. African Journal of Clinical and Experimental Microbiology Volume 11 (3): 170-173.
[34]
Ose Ugbegbor, MosesAigbirior, Favour Osazuwa, Ehigha Enabudoso and Omorogbe Zabayo (2011). The prevalence of Hepatitis B and C Viral infections among pregnant women attending antenatal at the University of Benin Teaching Hospital. North American Journal of medical Sciences: 3 (5). pp. 238-241.
[35]
M. A. Isa, U. K. Muhammad, S. B. Manga and H. K. Magga (2014). Prevalence of anti-hepatitis C Virus antibodies among patients attending Sokoto specialist Hospital Sokoto, Nigeria. Journal of Applied Sciences Research, 1 (4): 261-266.
[36]
Omar A. A. Aljooani, Noor N. Alhayani, Mahmood J. Mohammed (2012). The infection with HBV and HCV and their relationship to ABO blood group among Blood donor. Journal of Faculty of Medicine Baghdad. Volume 54. No 1.
[37]
Alireza Emami Naeni, Mojtaba Rostami and Sahar Emami Naeni (2010). Chronic Viral Hepatitis and their Relation to ABO blood group and Rhesus Factor. Academic Journal Volume 1 (1). pp. 5-7.
[38]
Belay Tessema, Gizachew Yismaw, Afework Kassu, Anteneh Amsalu, Andargachew Mulu, Frank Emmrichand Urich Sack (2010). Seroprevalence of HIV, HBV, HCV and Syphilis infections among blood donors at Gondar University Teaching Hospital North West Ethiopia: declining trends over a period of five years. BMC Infectious diseases DOI: 10.1186/1471-2334-10-111.
[39]
V. Walusansa and M. Kagimu (2009). Screening for Hepatitis C among HIV positive patients at Mulago Hospital, Uganda. African Health Sciences: 9 (3), pp. 143-146.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186